잠시만 기다려 주세요. 로딩중입니다.

Role of Biomarkers in Juvenile Idiopathic Arthritis

Journal of Rheumatic Diseases 2020년 27권 4호 p.233 ~ 240
안종균,
소속 상세정보
안종균 ( Ahn Jong-Gyun ) - Yonsei University College of Medicine Severance Children’s Hospital Department of Pediatrics

Abstract


The aim of this review was to identify the utility of biomarkers used in the diagnosis and the monitoring and treatment of Juvenile idiopathic arthritis (JIA). JIA is a heterogeneous group of diseases characterized by arthritis of unknown etiology that lasts for at least 6 weeks, with onset before the age of 16 years. Unlike adult rheumatoid arthritis, JIA is a heterogeneous arthritis with different subtypes. The diagnosis of JIA is based on clinical evaluation and often involves ruling out other causes of arthritis. Many biomarkers have been studied or are under development to define the classifications of JIA, assess disease activity, predict disease course, treatment response, or the risk of relapse. The diagnostic and prognostic use of biomarkers in JIA could be applied differently depending on diverse subtypes or individuals. To obtain the best clinical outcomes in JIA, it is important to understand the pathophysiology of each JIA subtype and to select and use appropriate biomarkers.

키워드

Juvenile idiopathic arthritis; Biomarkers; Outcome measures

원문 및 링크아웃 정보

등재저널 정보